Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 26, Issue 4, 1995, Pages 564-569

  Okada, Hirokazu ^a   Suzuki, Hiromichi ^a   Kanno, Yoshihiko ^a   Ikenaga, Hideki ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Hypertension; Nephrosclerosis; Proteinuria

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN ANTAGONIST; CANDESARTAN HEXETIL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MESSENGER RNA; POLYADENYLATED RNA; SERUM ALBUMIN; SODIUM CHLORIDE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INJURY; MALE; NEPHROSCLEROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL NEPHRECTOMY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RNA TRANSCRIPTION; SALT LOADING; SPONTANEOUSLY HYPERTENSIVE RAT; UREA NITROGEN BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; BLOTTING, NORTHERN; BODY WEIGHT; ENALAPRIL; HYPERTENSION; KIDNEY; MALE; NEPHRECTOMY; NEPHROSCLEROSIS; PROTEINURIA; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SODIUM, DIETARY; TRANSCRIPTION, GENETIC;

EID: 0029083749     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199510000-00009     Document Type: Article

References (48)

1. Weidmann P, Maxwell MH. The renin-angiotensin-aldo-sterone system in terminal renal failure. Kidney Int 1975;8:S219-34.
2. Katsumata H, Suzuki H, Ohishi A, Nakamoto H, Saruta T, Sakaguchi H. Effects of antihypertensive agents on blood pressure and the progress of renal failure in partially nephrectomized spontaneously hypertensive rats. Lab Invest 1990;62:474-80.
3. Terzi F, Beaufils H, Laouari D, Burtin M, Kleinknecht C. Renal effect of antihypertensive drugs depends on sodium diet in the excision remnant kidney model. Kidney Int 1992;42:354-63.
4. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652-9.
5. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons; a potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-93.
6. Meyer TW, Anderson S, Rennke HG, Brenner BM. Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 1987;31:752-9.
7. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rats. J Clin Invest 1986;77:1993-2000.
8. Yoshida Y, Kawamura T, Ikoma M, Fogo A, Ichikawa I. Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989;36:626-35.
9. Ikoma M, Kawamura T, Kakinuma Y, Fogo A, Ichikawa I. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int 1991;40:195-202.
10. Wolthuis A, Boes A, Rodemann HP, Grond J. Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells. Kidney Int 1992;41:124-31.
11. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987;59:59A-65A.
12. Ichikawa I, Harris RC. Angiotensin actions in the kidney: renewed insight into old hormone. Kidney Int 1991;40:583-96.
13. Farhy RD, Carretero OA, Ho KL, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 1993;72:1202-10.
14. Shibouta Y, Inada Y, Ojima M, et al. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]-1h-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug. J Pharmacol Exp Ther 1993;266:114-20.
15. Mizuno K, Niimura S, Tani M, et al. Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats. Life Sci 1992;51:183-7.
16. Noda M, Shibouta Y, Inada Y, et al. Inhibition of rabbit aortic angiotensin II (All) receptor by CV-11974, a new nonpeptide All antagonist. Biochem Pharmacol 1993;46:311-8.
17. Koh E, Morimoto S, Tomita J, et al. Effects of an angiotensin II receptor antagonist, CV-11974, on angiotensin II-induced increases in cytosolic free calcium concentration, hyperplasia, and hypertrophy of cultured vascular smooth muscle cells. J Cardiovasc Pharmacol 1994;23:175-9.
18. Kanno Y, Suzuki H, Okada H, Saruta T. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet. J Cardiovasc Pharmacol 1994;23:480-4.
19. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol 1992;37:235-8.
20. Feiner HD, Cabili S, Baldwin DS, Schacht RG, Gallo GR. Intrarenal vascular sclerosis in IgA nephropathy. Clin Nephrol 1982;18:183-92.
21. Iwai N, Yamano Y, Chaki S, et al. Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun 1991;177:299-304.
22. Umezawa A, Tachibana K, Harigaya K, et al. Colony-stimulating factor 1 expression is down-regulated during the adipocyte differentiation of H-l/A marrow stromal cells and induced by cachectin/tumor necrosis factor. Mol Cell Biol 1991;11:920-7.
23. Stier CT Jr, Benter IF, Ahmad S, et al. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 1989;13:115-21.
24. Clozel JP, Kuhn H, Hefti F. Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats. Am J Med 1989;87(suppl 6B):92S-5S.
25. Wexler RR, Carini DJ, Duncia JV, et al. Rationale for the chemical development of angiotensin II receptor antagonists. Am J Hypertens 1992;5:209S-20S.
26. Gansevoort RT, De Zeeuw D, Shahinfar S, Redfield A, De Jong PE. Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease. J Hypertens 1994;12(suppl 2):S37-42.
27. Wood JM, Schnell CR, Levens NR. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats. Hypertension 1993;21:1056-61.
28. Prescott MF, Webb RL, Reidy MA. Angiotensin-Converting enzyme inhibitor versus angiotensin II, ATI receptor antagonist. Am J Pathol 1991;139:1291-6.
29. von Lutterotti N, Camargo MJF, Campbell WG Jr, et al. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J Hypertens 1992;10:949-57.
30. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 1992;42:46-55.
31. Kohara K, Mikami H, Okuda J, Higaki J, Ogihara T. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat. Hypertension 1993;21:975-9.
32. Gansevoort RT, de Zeeuw D, de Jong PE. Antiproteinuric effects of the angiotensin-II receptor antagonist MK-954 in non-diabetic renal disease. J Am Soc Nephrol 1992;3:282.
33. Baboolal K, Meyer TW. Acute angiotensin II receptor blockade does not reverse systemic or glomerular capillary hypertension in remnant kidney rats. J Am Soc Nephrol 1992;3:557.
34. Camargo MJF, von Lutterotti N, Pecker MS, James GD, Timmermans PBMWM, Laragh JH. DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet. Am J Hypertens 1991;4(suppl 4):341S-5S.
35. von Lutterotti N, Camargo MJF, Campbell WG Jr, et al. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J Hypertens 1992;10:949-57.
36. Janiak P, Pillon A, Prost JF, Vilaine JP. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992;20:737-45.
37. Gomez RA. Angiotensin receptors: relevance in development and disease states. Exp Nephrol 1994;2:259-68.
38. Gibson RE, Thorpe HH, Cartwright ME, et al. Angiotensin II receptor subtypes in renal cortex of rats and Rhesus monkeys. Am J Physiol 1991;261:F512-8.
39. Timmermans PBMWM, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD. Angiotensin II receptors and functional correlates. Am J Hypertens 1992;5:221S-5S.
40. Widdop RE, Gardiner SM, Kem PA, Benne T. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the ATI-receptor antagonist, EXP 3174. Br J Pharmacol 1992;107:873-80.
41. Edwards RM, Stack EJ, Weidley EF, et al. Characterization of renal angiotensin II receptors using subtype selective antagonists. J Pharmacol Exp Ther 1992;260:933-8.
42. Zhou J, Ernsberger P, Douglas JG. A novel angiotensin receptor subtype in rat mesangium. Hypertension 1993;21:1035-8.
43. Hayashi K, Suzuki H, Saruta T. Segmental differences in angiotensin receptor subtypes in the interlobular artery of hydronephrotic rat kidneys. Am J Physiol 1993;265:F881-5.
44. Swanson GN, Hanesworth JM, Sardinia MF, et al. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 1992;40:409-19.
45. Iwai N, Inagami T. Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun 1992;182:1094-9.
46. Kitami Y, Okura T, Marumoto K, Wakamiya R, Hiwada K. Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 1992;188:446-52.
47. Elton TS, Stephan CC, Taylor GR, et al. Isolation of two distinct type 1 angiotensin II receptor genes. Biochem Biophys Res Commun 1992;184:1067-73.
48. Tufro-McReddie A, Chevalier RL, Everett AD, Gomez RA. Decreased perfusion pressure modulates renin and Ang II type 1 receptor gene expression in the rat kidney. Am J Physiol 1993;264:R696-702.